Harmony Biosciences Holdings, Inc.
HRMY
$28.46
$0.521.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 8.19% | 7.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.19% | 7.65% | |||
| Cost of Revenue | 27.19% | 33.08% | |||
| Gross Profit | 2.51% | 1.84% | |||
| SG&A Expenses | 0.54% | 0.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.06% | -17.91% | |||
| Operating Income | -9.70% | 188.96% | |||
| Income Before Tax | -9.68% | 186.58% | |||
| Income Tax Expenses | -58.45% | 59.13% | |||
| Earnings from Continuing Operations | 7.34% | 297.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.34% | 297.66% | |||
| EBIT | -9.70% | 188.96% | |||
| EBITDA | -8.84% | 146.93% | |||
| EPS Basic | 6.91% | 297.11% | |||
| Normalized Basic EPS | -10.03% | 186.22% | |||
| EPS Diluted | 7.37% | 295.00% | |||
| Normalized Diluted EPS | -9.84% | 183.83% | |||
| Average Basic Shares Outstanding | 0.40% | 0.12% | |||
| Average Diluted Shares Outstanding | 0.20% | 0.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||